返回
Argent Biopharma Ltd (RGTLF) 收益
关键数据
前收盘价
$0.03
开盘价
$0.03
当日区间
$0.03 - $0.03
52周范围
$0.0105 - $0.2092
交易量
10.0K
平均成交量
3.1K
股息收益率
--
每股收益（TTM）
-0.22
市值
$2.6M
什么是 Argent BioPharma Limited？
Argent BioPharma Ltd. engages in the production of medical marijuana. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2006-12-21. The Company’s assets, CannEpil and CimetrA, target immune dysregulation in drug-resistant epilepsy and cytokine-driven inflammatory disorders, respectively. The Company’s proprietary delivery technologies enhance penetration across the blood-brain and alveolar-capillary barriers, supporting differentiated efficacy and composition-of-matter protection. The company focuses on urgent unmet needs in the central nervous system (CNS) and systemic inflammation. Its product pipeline includes CimetrA, CannEpil, CogniCann and others. CannEpil is a refractory epilepsy seizure control treatment. CogniCann is an investigational oral spray developed by the Company to help manage symptoms associated with dementia and Alzheimer’s disease. The firm has a patient base in Australia, the United Kingdom, Brazil, and Ireland.